2022
DOI: 10.1007/s00264-022-05416-y
|View full text |Cite
|
Sign up to set email alerts
|

Is intravenous tranexamic acid effective in reduction of blood loss during pelvic and acetabular surgery?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…There have been several recent studies evaluating the use of TXA for pelvis and acetabular surgery. [2][3][4][5] Two of these studies were meta-analyses where one showed TXA did decrease transfusion and the other showed TXA did not decrease transfusion; however, both studies combined analysis for both pelvis and acetabular fracture surgery, with any approach used for acetabular exposure. 3,4 Another recent, prospective randomized double-blind study evaluating the use of TXA in 63 patients with open treatment for acetabular fractures showed TXA did not affect transfusion rates or blood loss.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…There have been several recent studies evaluating the use of TXA for pelvis and acetabular surgery. [2][3][4][5] Two of these studies were meta-analyses where one showed TXA did decrease transfusion and the other showed TXA did not decrease transfusion; however, both studies combined analysis for both pelvis and acetabular fracture surgery, with any approach used for acetabular exposure. 3,4 Another recent, prospective randomized double-blind study evaluating the use of TXA in 63 patients with open treatment for acetabular fractures showed TXA did not affect transfusion rates or blood loss.…”
Section: Discussionmentioning
confidence: 99%
“…Many surgeons hold VTE prophylaxis the morning of surgery for large cases such as ORIF of the acetabulum and give TXA in an attempt to reduce transfusion with little evidence these interventions are effective. [2][3][4][5]7,8 We attempted to look at several factors that might affect transfusion rates including but not limited to TXA use and holding VTE prophylaxis when performing the AIP approach.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…8 Intravenous TXA is used in various surgical specialties, such as cardiac surgery, orthopaedic surgery, and obstetrics, where it reduces perioperative blood loss and the need for transfusion by one-third. [9][10][11][12][13] TXA is efficacious in reducing blood loss when used topically during surgery, intravenously with or without postoperative maintenance treatment, or the abovementioned combination. The reported topical dose of TXA ranges from 1 to 3 g TXA per 100 mL saline, with no optimal dose established.…”
mentioning
confidence: 99%